Frost & Sullivan awarded BioTrove, a Woburn, Massachusetts developer of mass spectrometry and qPCR (quantitative real time polymerase chain reaction) technology, with the 2009 North American Award for Growth Strategy Leadership of the Year. F&S bases the prize on an “analysis of the most significant drug-discovery innovations and acknowledgments by life sciences category leaders.”
Here’s a bit about the company’s technology:
The OpenArray® technology enables researchers to perform large-volume nanoliter arrays, conducting up to 3,000 assays simultaneously, while the RapidFire® Mass Spectrometry (RF-MS) technology uses microfluidics to conduct sample analysis 10-to-100 times faster than conventional liquid chromatography-mass spectrometry (LC-MS) technologies.
“These solid technologies facilitate faster, higher-throughput and ultimately more efficient research and drug discovery,” said Frost & Sullivan Research Analyst Christi Bird. “In addition to directly distributing these products to end-users, BioTrove has also collaborated with several top life sciences tool and services providers to develop optimized products, services and workflows utilizing OpenArray® or RapidFire® technologies.”